Verdict at a Glance These peptides serve entirely different purposes and are not interchangeable
Yes, clinical trials have shown comparable results in glucose control and weight loss, depending on dose and adherence
It promotes soft tissue healing by increasing the motility of repair cells and reducing inflammation through mechanisms distinct from those of penta deca peptide arginate
By the mid-1980s, the amino acid sequence for GLP-1 was discovered
Furthermore, early clinical studies have reported that FokI, TaqI, and the A-1012G promoter polymorphism are positively associated with favorable responses to calcipotriol, lending support to the pharmacogenetic framework in which drug response is modulated by genetic background [282]
Overall, this combination has been shown to improve glycemic control and reduce body weight with low risk of hypoglycemia